Our results demonstrate that CFZ induced apoptosis and enhanced doxorubicin (Dox)-induced apoptosis through inhibiting the NF-κB activation and activating p38 and JNK pathway in NB. This evidence concerns the gene NFKB1 and neuroblastoma.